Hungarian pharmaceutical company Gedeon Richter announced on Tuesday the acquisition of the women's health discovery portfolio of US-based biotech company Celmatix. The portfolio includes assets targeting fertility, endometriosis and ovarian ageing. The development of the acquired programmes will be led by Richter's women's health R+D hub in Belgium. Celmatix will receive an upfront payment and […]